WisdomTree Global ex-U.S. Quality Growth Fund DNL
42.54 USD -0.52 (-1.21%)
At closeNov 10, 2026, 4:15 PM EST
42.54 0.00 0.00%
After hours · Nov 10, 4:15 PM ET
42.26 Day range 42.92
38.95 52-week range 47.24
- YTD
- +3.20%
- 1 year
- +3.32%
News
globenewswire.com Denali Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights AVLAYAH® (tividenofusp alfa-eknm) net product revenue accelerated to $17.8 million in its second full commercial quarter Continued growth expectations drive Q4 2026 net product revenue guidance of…
benzinga.com What's Going On With Shopify Stock Tuesday? Shopify (SHOP) fell nearly 8% as investors rotated away from high-multiple growth stocks despite strong Q2 earnings. Learn more.
globenewswire.com The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics' Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II) SOUTH SAN FRANCISCO, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced the publication of results from the open-label Phase 1/2 clinical trial of its…
seekingalpha.com Denali: Maintaining Strong Buy Based On DNL126 Expansion As MPS IIIA Treatment Denali Therapeutics Inc. is maintained at a Strong Buy rating, driven by progress in its MPS II [Hunter Syndrome] program with tividenofusp alfa. Despite discontinuing ALS efforts, DNLI's BLA for…
zacks.com Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now? The WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) was launched on 06/16/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the World ETFs category of the…
zacks.com Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now? A smart beta exchange traded fund, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) debuted on 06/16/2006, and offers broad exposure to the World ETFs category of the market.
zacks.com Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now? Launched on 06/16/2006, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) is a smart beta exchange traded fund offering broad exposure to the World ETFs category of the market.
seekingalpha.com DNL: Lagging Its Peers For A While WisdomTree Global ex‐U.S. Quality Dividend Growth Fund holds 300 ex-US dividend stocks, focusing on quality and growth metrics. DNL is diversified across holdings, sectors, and countries, with…
globenewswire.com Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126 Through START Program SOUTH SAN FRANCISCO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), today announced that the company's initiation of a rolling submission of a biologics license…
zacks.com Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now? Designed to provide broad exposure to the World ETFs category of the market, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) is a smart beta exchange traded fund launched on…
seekingalpha.com Denali Therapeutics: Vast Pipeline, First Approval Up Ahead Denali Therapeutics' stock has significantly dropped from $100 to $15 since 2021, but the company is now heavily derisked with promising product candidates nearing key milestones. Lead asset DNL310…
zacks.com Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now? Designed to provide broad exposure to the World ETFs category of the market, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) is a smart beta exchange traded fund launched on…
globenewswire.com Denali Therapeutics Announces Topline Results for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial SOUTH SAN FRANCISCO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI) today announced topline results from an analysis of Regimen G of the Phase 2/3 HEALEY ALS…
zacks.com Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now? Designed to provide broad exposure to the World ETFs category of the market, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) is a smart beta exchange traded fund launched on…
zacks.com Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now? Launched on 06/16/2006, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) is a smart beta exchange traded fund offering broad exposure to the World ETFs category of the market.
globenewswire.com Denali Therapeutics Announces Successful Meeting with the FDA and Plans to File for Accelerated Approval of Tividenofusp Alfa (DNL310) for the Treatment of MPS II (Hunter Syndrome) SOUTH SAN FRANCISCO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced the outcome of a recent successful meeting with the Center for Drug Evaluation…
seekingalpha.com Denali Therapeutics: A Promising Biotech With Revolutionary BBB-Crossing Technology Denali Therapeutics' proprietary Transport Vehicle technology enables drug delivery across the blood-brain barrier, targeting neurodegenerative diseases. DNL310, targeting MPS II, and DNL343 for ALS…
zacks.com Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now? Launched on 06/16/2006, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) is a smart beta exchange traded fund offering broad exposure to the World ETFs category of the market.
zacks.com Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now? The WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) made its debut on 06/16/2006, and is a smart beta exchange traded fund that provides broad exposure to the World ETFs category of the…
zacks.com Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now? The WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) made its debut on 06/16/2006, and is a smart beta exchange traded fund that provides broad exposure to the World ETFs category of the…
seekingalpha.com ICOW: Attractive Fundamentals, Average Performance ICOW: Attractive Fundamentals, Average Performance
benzinga.com Denali Therapeutics Late Wednesday Announces Pricing Of $275M Public Offering Of 10,377,359 Shares Of Common Stock For $26.50 Per Share Denali Therapeutics Inc. (NASDAQ:DNLI) today announced the pricing of its underwritten public offering of 10,377,359 shares of its common stock at a price to the public of $26.50 per share. All of…
benzinga.com New ETF Brings Dividend Growth Concept to Emerging Markets 
benzinga.com Three Ex-U.S. ETFs Your Broker Forgot to Mention 
benzinga.com 4 "Ex" ETFs Your Broker Forgot to Mention (DTN, AXEN, FDT) 
benzinga.com Immunomedics Reports Clinical Results of Pretargeted Radioimmunotherapy of Colorectal Cancer 
benzinga.com Five International Dividend ETFs Your Broker Forgot to Mention - benzinga.com Immunomedics Reports First Clinical Results of New Antibody-Directed Radiation Therapy for Colorectal Cancer
- benzinga.com Goldman Sachs Expects A Correction In Asian Stocks In 2010 (EWY, FXI, SCJ, DNL)